Status:
COMPLETED
Avelox in Complicated Skin and Skin Structure Infections
Lead Sponsor:
Bayer
Conditions:
Skin Diseases, Bacterial
Eligibility:
All Genders
10+ years
Brief Summary
This international, prospective, non-interventional, non-controlled observational study obtains data on efficacy, safety and tolerability of Avelox treatment under daily-life treatment conditions. Spe...
Eligibility Criteria
Inclusion
- Any patient with a diagnosis of complicated skin and skin structure infection (cSSSI) and for whom the decision was made by the attending physician to start treatment with Avelox before inclusion into and independent of the study.
Exclusion
- Exclusion criteria are those specified in the local product information.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
6127 Patients enrolled
Trial Details
Trial ID
NCT00997997
Start Date
October 1 2005
End Date
December 1 2008
Last Update
November 16 2012
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Austria
2
Many Locations, Bulgaria
3
Many Locations, Egypt
4
Many Locations, Germany